twenty-one patients with proven recurrent malignant pleural effusions were randomly allocated to treatment groups receiving either intrapleural corynebacterium parvum in a dose of 7 mg or intrapleural mustine ( 20 mg ) .
C0080032
malignant pleural effusions
C0025033
mustine